CHMMF
Chimeric Therapeutics Limited
Set alert
0.10 USD 0.00 0.00%
0.001 Day range 0.001
0.001 52-week range 0.10
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.001
- Prev close
- 0.10
- Mkt cap
- 14.75M
- Vol
- 30.00K
- Avg vol
- 0
- EPS
- -1.12
- P/E
- 0.00
More statistics
- Low
- 0.001
- High
- 0.001
Financial health
Altman Z-Score
-131.23 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.2×
FY 2020 5y median -0.3× FY 2026
P/S 0.0×
FY 2020 5y median 0.5× FY 2026
P/B -0.6×
FY 2020 5y median 1.3× FY 2026
P/FCF 0.0×
FY 2020 5y median -0.5× FY 2026
EV/EBITDA -0.5×
FY 2020 5y median -0.5× FY 2026
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2026
FCF Yield 0.0%
FY 2020 5y median -40.4% FY 2026
Profitability
Gross Margin 0.0%
FY 2020 5y median 63.7% FY 2026
Operating Margin 0.0%
FY 2020 5y median -380.8% FY 2026
Net Margin 0.0%
FY 2020 5y median -262.8% FY 2026
ROE 243.6%
FY 2020 5y median -450.5% FY 2026
ROIC 120.6%
FY 2020 5y median -217.2% FY 2026
ROA -1470.9%
FY 2020 5y median -82.0% FY 2026
Growth (YoY)
Revenue -100.0%
FY 2020 FY 2026
Operating Income 44.8%
FY 2020 FY 2026
EPS (diluted) 20.8%
FY 2020 FY 2026
Free Cash Flow 100.0%
FY 2020 FY 2026
Financial Health
Current Ratio 0.1×
FY 2020 5y median 0.6× FY 2026
Quick Ratio 0.1×
FY 2020 5y median 0.6× FY 2026
Debt / Equity -0.1×
FY 2020 5y median 0.0× FY 2026
Net Debt / EBITDA 0.0×
FY 2020 5y median 0.1× FY 2026
Interest Coverage 0.0×
FY 2020 5y median -32.4× FY 2026
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-06-30